Tevra Brands LLC v. Bayer HealthCare LLC
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 TEVRA BRANDS LLC, Case No. 19-cv-04312-BLF
Plaintiff,
ORDER REGARDING MOTIONS IN
v. LIMINE
BAYER HEALTHCARE LLC, et al., [Re: ECF Nos. 368, 370, 371, 372, 373, Defendants. 374]
12 On June 13, 2024, the Court held a pretrial conference in this action, during which it issued oral rulings on Plaintiff Tevra Brands LLC.’s (“Tevra”) and Defendant Bayer Healthcare LLC.’s (“Bayer”) motions in limine. ECF No. 407 (“Hearing Tr.”). The Court here expands upon those oral rulings. I. BACKGROUND Tevra brings this antitrust action against Bayer alleging it engaged in exclusionary practices that substantially restrained trade in the market for topical imidacloprid flea and tick treatments for dogs and cats. Tevra’s Second Amended Complaint alleges three claims: violations of Sections 1 and 2 of the Sherman Act (exclusive dealing and maintenance of a monopoly) and …